Drawing for PURE RELIEF

USPTO serial 87833205

PURE RELIEF

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PURE RELIEF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations for chloasma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Collodion for pharmaceutical purposes; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposesABANDONEDFeb 15, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 9, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Jan 9, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Jan 9, 2019OP.TOPPOSITION TERMINATED NO. 999999
Jan 9, 2019OP.SOPPOSITION SUSTAINED NO. 999999
Oct 1, 2018OP.IOPPOSITION INSTITUTED NO. 999999
Aug 21, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jul 31, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2018DOCKASSIGNED TO EXAMINER
Mar 20, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance